 "Eye Flu")
Glenmark Pharmaceuticals on Monday said its US-based subsidiary has introduced a generic medication used for eye itching.
Glenmark Therapeutics Inc, USA has launched Olopatadine Hydrochloride Ophthalmic Solution (OTC) in the US market, the Mumbai-based drug maker said in a regulatory filing.
Fabio Moreno, Head of OTC Sales & Marketing, Glenmark Pharmaceuticals Inc, said the launch of Olopatadine Ophthalmic Solution (USP, 0.1 per cent), addresses a growing demand for a new supplier in this category.
"This addition highlights our commitment to meeting market needs and providing high-quality over-the-counter solutions for our customers," Moreno said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
 "market, stocks, stock market trading, stock market")
 "Glenmark Pharmaceuticals")
 "Glenmark Pharmaceuticals")
 "Market, BSE, NSE, NIfty")
